Hyperhomocysteinemia and venous thrombosis

G M Bos1, M den Heijer

  • 1University Hospital Rotterdam/Daniel den Hoed Cancer Center, The Netherlands.

Insights

Hyperhomocysteinemia is a risk factor for vascular issues like venous thrombosis. While easily treated with vitamins, ongoing studies investigate if lowering homocysteine levels prevents recurrent thrombosis.

Area of Science:

  • Cardiovascular Medicine
  • Thrombosis Research

Background:

  • Hyperhomocysteinemia is increasingly recognized as a risk factor for various conditions, including neural tube defects, arterial cardiovascular disease, and venous thrombosis.
  • The association between hyperhomocysteinemia and vascular diseases, particularly venous thrombosis, has garnered significant attention.

Purpose of the Study:

  • To discuss hyperhomocysteinemia, its causes, and its association with venous thrombosis.
  • To evaluate the diagnostic utility of the methionine loading test for hyperhomocysteinemia.
  • To explore therapeutic options and ongoing research into the clinical relevance of lowering homocysteine levels for preventing recurrent venous thrombosis.

Main Methods:

  • Review of existing case-control and prospective studies on hyperhomocysteinemia and venous thrombosis.
  • Discussion of potential mechanisms linking hyperhomocysteinemia to venous thrombosis.
  • Description of a current international multicenter, placebo-controlled study investigating the efficacy of homocysteine level reduction.

Main Results:

  • Several case-control studies suggest an association between venous thrombosis and hyperhomocysteinemia.
  • Evidence for a causal relationship, especially for mild hyperhomocysteinemia, remains limited.
  • Hyperhomocysteinemia is generally treatable with vitamin supplementation.

Conclusions:

  • While an association exists, the causal role of mild hyperhomocysteinemia in venous thrombosis requires further investigation.
  • Ongoing research aims to determine the clinical significance of reducing homocysteine levels in preventing recurrent venous thrombosis.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...